Baader Bank set a €52.00 ($60.47) target price on Compugroup Medical (ETR:COP) in a research report released on Monday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
A number of other research analysts also recently issued reports on COP. Berenberg Bank set a €70.00 ($81.40) price objective on Compugroup Medical and gave the company a neutral rating in a research note on Thursday, August 1st. Deutsche Bank set a €68.00 ($79.07) price objective on Compugroup Medical and gave the company a buy rating in a research note on Wednesday, August 21st. HSBC set a €59.00 ($68.60) price objective on Compugroup Medical and gave the company a buy rating in a research note on Wednesday, August 21st. Finally, Kepler Capital Markets set a €70.00 ($81.40) price objective on Compugroup Medical and gave the company a buy rating in a research note on Monday, June 3rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of €57.75 ($67.15).
Shares of ETR:COP opened at €54.90 ($63.84) on Monday. The company has a market capitalization of $2.70 billion and a PE ratio of 33.66. The company has a debt-to-equity ratio of 147.29, a current ratio of 0.90 and a quick ratio of 0.70. The business has a fifty day moving average price of €56.61 and a two-hundred day moving average price of €59.70. Compugroup Medical has a 1 year low of €37.88 ($44.05) and a 1 year high of €74.80 ($86.98).
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Featured Story: What are gap-down stocks?
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.